{
  "articles": [
    {
      "path": "about.html",
      "title": "About this site",
      "description": "Some additional details about the website",
      "author": [],
      "contents": "\r\nBorn frequentist, Francois Mercier gradually developed an interest for the Bayesian formalism and use it now as main M&S framework.\r\nHe frequently collaborates with statistical engineers, and researchers who study Bayesian causal inference and machine learning.\r\nHe has contributed to\r\n* 50+ clinical development programs (Phase 1 to Phase 3),\r\n* 4 NDAs (Fingolimod, Siponimod, Ocrelizumab, and Entrectinib.\r\n* 50+ scientific articles in statistics and clinical journals,\r\n* 100+ scientific posters,\r\n* 40+ oral communications in major conferences.\r\n\r\n\r\n\r\n",
      "last_modified": "2023-08-19T18:04:52+02:00"
    },
    {
      "path": "index.html",
      "title": "Francois Mercier",
      "author": [],
      "contents": "\r\n\r\n          \r\n          \r\n          mercifr1 pages\r\n          \r\n          \r\n          Home\r\n          About\r\n          ☰\r\n          \r\n          \r\n      \r\n        \r\n          \r\n            \r\n              \r\n            \r\n              Francois Mercier\r\n            \r\n            \r\n              \r\n                \r\n                    \r\n                      \r\n                        LinkedIn\r\n                      \r\n                    \r\n                  \r\n                                    \r\n                    \r\n                      \r\n                        GitHub\r\n                      \r\n                    \r\n                  \r\n                                    \r\n                    \r\n                      \r\n                        Email\r\n                      \r\n                    \r\n                  \r\n                                  \r\n            \r\n          \r\n        \r\n        \r\n        \r\n          \r\n            I am a Distinguished Scientist in Modeling and Simulation\r\n            at the Roche\r\n            Innovation Center in Basel, in Basel.\r\n            After completion of a Ph.D. in Modeling and Simulation of\r\n            Biology Systems at (Univ. Lyon 1), I\r\n            started working in clinical development in 1997. Endorsing\r\n            various roles (data scientist, statistician,\r\n            pharmacometrician) during my career, I have had the\r\n            opportunity to work in different countries (France,\r\n            Switzerland, USA) and different settings for the\r\n            pharmaceutical industry: in a small company (Laboratoires\r\n            Fournier, now Inventiva), a CRO\r\n            specializing in model-based drug development (Certara), and two of the\r\n            largest pharmaceutical groups (Novartis and Roche).\r\n            I use semi-mechanistic and statistical models of clinical\r\n            data to support decision-making in drug development. My\r\n            research focuses mainly on dose-finding, and\r\n            composite data models such as joint models.\r\n            I have also started evaluating the potential of\r\n            Bayesian causal inference and machine\r\n            learning.\r\n            So far, I have contributed to\r\n            50+ clinical development programs (Phase 1 to Phase\r\n            3)\r\n            4 NDAs (fingolimod, siponimod, ocrelizumab, and\r\n            entrectinib)\r\n            50+ scientific articles in statistics and clinical\r\n            journals\r\n            60+ scientific posters\r\n            40+ oral communications in statistics and\r\n            pharmacometrics conferences.\r\n            \r\n        \r\n      \r\n    \r\n\r\n    \r\n      \r\n        \r\n          \r\n            \r\n              \r\n            \r\n              Francois Mercier\r\n            \r\n            \r\n              \r\n                \r\n                                    \r\n                    \r\n                      LinkedIn\r\n                    \r\n                  \r\n                                    \r\n                    \r\n                      GitHub\r\n                    \r\n                  \r\n                                    \r\n                    \r\n                      Email\r\n                    \r\n                  \r\n                                  \r\n              \r\n            \r\n            \r\n              I am a Distinguished Scientist in Modeling and\r\n              Simulation at the Roche\r\n              Innovation Center in Basel, in Basel.\r\n              After completion of a Ph.D. in Modeling and Simulation\r\n              of Biology Systems at (Univ. Lyon 1), I\r\n              started working in clinical development in 1997. Endorsing\r\n              various roles (data scientist, statistician,\r\n              pharmacometrician) during my career, I have had the\r\n              opportunity to work in different countries (France,\r\n              Switzerland, USA) and different settings for the\r\n              pharmaceutical industry: in a small company (Laboratoires\r\n              Fournier, now Inventiva), a CRO\r\n              specializing in model-based drug development (Certara), and two of\r\n              the largest pharmaceutical groups (Novartis and Roche).\r\n              I use semi-mechanistic and statistical models of\r\n              clinical data to support decision-making in drug\r\n              development. My research focuses mainly on\r\n              dose-finding, and composite data models such as\r\n              joint models.\r\n              I have also started evaluating the potential of\r\n              Bayesian causal inference and machine\r\n              learning.\r\n              So far, I have contributed to\r\n              50+ clinical development programs (Phase 1 to Phase\r\n              3)\r\n              4 NDAs (fingolimod, siponimod, ocrelizumab, and\r\n              entrectinib)\r\n              50+ scientific articles in statistics and clinical\r\n              journals\r\n              60+ scientific posters\r\n              40+ oral communications in statistics and\r\n              pharmacometrics conferences.\r\n              \r\n        \r\n      \r\n    \r\n\r\n    \r\n    \r\n    ",
      "last_modified": "2024-01-05T14:18:54+01:00"
    }
  ],
  "collections": []
}
